OmniVis uses a revolutionary sensing technique to quantify and analyze biomolecular solutions directly at the source. OmniVis’s easy to use hardware device and consumable test kit attaches to a smartphone and reduces the detection process to 30 minutes, accurately and affordably. Data gathering and reporting tools provide insights over disease hotspots; enabling users to prevent outbreaks before they happen.  Founded in 2017, OmniVis is focused on developing devices for use in biotechnology specifically in global health and biotherapeutics.